Jyong Biotech Ltd. (MENS)
NGM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
Jyong Biotech Ltd. has not issued a press release in this window.
SEC filings
All filings →Jyong Biotech Ltd. has not filed an SEC document in this window.
Insider trades
All insider trades →Jyong Biotech Ltd. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Jyong Biotech Ltd.
All people →No officers or directors have been indexed for Jyong Biotech Ltd..
Quarterly financials
Full financials →No quarterly financials have been ingested for Jyong Biotech Ltd..